Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions

Background and Aim: Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulopathy. The Oxford classification was recently updated to include crescents as markers of poor prognosis. The aim of this study was to evaluate the impact of cellular crescents on the prognosis of patients wit...

Full description

Bibliographic Details
Main Authors: Precil Diego Miranda de Menezes Neves, Rafaela Bezerra Brito Pinheiro, Cristiane Bitencourt Dias, Luis Yu, Leonardo de Abreu Testagrossa, Lívia Barreira Cavalcante, Denise Maria Avancini Costa Malheiros, Lectícia Barbosa Jorge, Viktoria Woronik
Format: Article
Language:English
Published: Karger Publishers 2020-04-01
Series:Kidney & Blood Pressure Research
Subjects:
Online Access:https://www.karger.com/Article/FullText/507251
id doaj-394306aa95834dbfaef7dec6a5900972
record_format Article
spelling doaj-394306aa95834dbfaef7dec6a59009722020-11-25T03:10:53ZengKarger PublishersKidney & Blood Pressure Research1420-40961423-01432020-04-0111110.1159/000507251507251Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic LesionsPrecil Diego Miranda de Menezes NevesRafaela Bezerra Brito PinheiroCristiane Bitencourt DiasLuis YuLeonardo de Abreu TestagrossaLívia Barreira CavalcanteDenise Maria Avancini Costa MalheirosLectícia Barbosa JorgeViktoria WoronikBackground and Aim: Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulopathy. The Oxford classification was recently updated to include crescents as markers of poor prognosis. The aim of this study was to evaluate the impact of cellular crescents on the prognosis of patients with IgAN in Brazil. Methods: This was a single-centre retrospective analysis of medical records and renal biopsies in patients with IgAN. The renal biopsy findings were classified according to the revised Oxford classification: mesangial hypercellularity, endocapillary hypercellularity (E), segmental glomerulosclerosis (S), tubular atrophy or interstitial fibrosis (T), and crescent formation (C). We evaluated a composite outcome (progression to end-stage renal disease or creatinine doubling). We performed analyses between the patients with crescents in the renal biopsy specimen (C1/C2 group) and those without such crescents (C0 group). Results: We evaluated 111 patients, of whom 72 (65.0%) were women, 80 (72.0%) self-identified as White, 73 (65.6%) were hypertensive, and 95 (85.6%) had haematuria. The distribution of patients according to cellular crescentic lesions was: C0, 80 (72%); C1, 27 (24.4%); C2, 4 (3.6%). The composite outcome was observed in 33 (29.72%) of the 111 patients. In comparison with the C0 group, the C1/C2 group had higher proportions of patients with hypertension (p = 0.04), haematuria (p = 0.03), worse serum creatinine (p = 0.0007), and worse estimated glomerular filtration rate (p = 0.0007). The C1/C2 group also had higher proportions of patients in whom the biopsy specimen was classified as E1 (p = 0.009), S1 (p = 0.001), or T1/T2 (p = 0.03), In addition, the mean follow-up period was shorter in the C1/C2 group (p < 0.0001). Furthermore, the composite outcome was observed in a greater proportion of patients and in a shorter length of time in the C1/C2 group than in the C0 group (p = 0.002 and p = 0.0014, respectively). In a Cox regression analysis, the independent risk factors for the composite outcome had Oxford classifications of S1, T1/T2, and C1/C2. Conclusion: Oxford classification findings of S1, T1/T2, or C1/C2 were independent risk factors for the composite outcome, corroborating previous studies.https://www.karger.com/Article/FullText/507251pathologyend-stage renal diseaseimmunoglobulin a nephropathykidney biopsy
collection DOAJ
language English
format Article
sources DOAJ
author Precil Diego Miranda de Menezes Neves
Rafaela Bezerra Brito Pinheiro
Cristiane Bitencourt Dias
Luis Yu
Leonardo de Abreu Testagrossa
Lívia Barreira Cavalcante
Denise Maria Avancini Costa Malheiros
Lectícia Barbosa Jorge
Viktoria Woronik
spellingShingle Precil Diego Miranda de Menezes Neves
Rafaela Bezerra Brito Pinheiro
Cristiane Bitencourt Dias
Luis Yu
Leonardo de Abreu Testagrossa
Lívia Barreira Cavalcante
Denise Maria Avancini Costa Malheiros
Lectícia Barbosa Jorge
Viktoria Woronik
Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions
Kidney & Blood Pressure Research
pathology
end-stage renal disease
immunoglobulin a nephropathy
kidney biopsy
author_facet Precil Diego Miranda de Menezes Neves
Rafaela Bezerra Brito Pinheiro
Cristiane Bitencourt Dias
Luis Yu
Leonardo de Abreu Testagrossa
Lívia Barreira Cavalcante
Denise Maria Avancini Costa Malheiros
Lectícia Barbosa Jorge
Viktoria Woronik
author_sort Precil Diego Miranda de Menezes Neves
title Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions
title_short Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions
title_full Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions
title_fullStr Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions
title_full_unstemmed Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions
title_sort renal outcomes in brazilian patients with immunoglobulin a nephropathy and cellular crescentic lesions
publisher Karger Publishers
series Kidney & Blood Pressure Research
issn 1420-4096
1423-0143
publishDate 2020-04-01
description Background and Aim: Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulopathy. The Oxford classification was recently updated to include crescents as markers of poor prognosis. The aim of this study was to evaluate the impact of cellular crescents on the prognosis of patients with IgAN in Brazil. Methods: This was a single-centre retrospective analysis of medical records and renal biopsies in patients with IgAN. The renal biopsy findings were classified according to the revised Oxford classification: mesangial hypercellularity, endocapillary hypercellularity (E), segmental glomerulosclerosis (S), tubular atrophy or interstitial fibrosis (T), and crescent formation (C). We evaluated a composite outcome (progression to end-stage renal disease or creatinine doubling). We performed analyses between the patients with crescents in the renal biopsy specimen (C1/C2 group) and those without such crescents (C0 group). Results: We evaluated 111 patients, of whom 72 (65.0%) were women, 80 (72.0%) self-identified as White, 73 (65.6%) were hypertensive, and 95 (85.6%) had haematuria. The distribution of patients according to cellular crescentic lesions was: C0, 80 (72%); C1, 27 (24.4%); C2, 4 (3.6%). The composite outcome was observed in 33 (29.72%) of the 111 patients. In comparison with the C0 group, the C1/C2 group had higher proportions of patients with hypertension (p = 0.04), haematuria (p = 0.03), worse serum creatinine (p = 0.0007), and worse estimated glomerular filtration rate (p = 0.0007). The C1/C2 group also had higher proportions of patients in whom the biopsy specimen was classified as E1 (p = 0.009), S1 (p = 0.001), or T1/T2 (p = 0.03), In addition, the mean follow-up period was shorter in the C1/C2 group (p < 0.0001). Furthermore, the composite outcome was observed in a greater proportion of patients and in a shorter length of time in the C1/C2 group than in the C0 group (p = 0.002 and p = 0.0014, respectively). In a Cox regression analysis, the independent risk factors for the composite outcome had Oxford classifications of S1, T1/T2, and C1/C2. Conclusion: Oxford classification findings of S1, T1/T2, or C1/C2 were independent risk factors for the composite outcome, corroborating previous studies.
topic pathology
end-stage renal disease
immunoglobulin a nephropathy
kidney biopsy
url https://www.karger.com/Article/FullText/507251
work_keys_str_mv AT precildiegomirandademenezesneves renaloutcomesinbrazilianpatientswithimmunoglobulinanephropathyandcellularcrescenticlesions
AT rafaelabezerrabritopinheiro renaloutcomesinbrazilianpatientswithimmunoglobulinanephropathyandcellularcrescenticlesions
AT cristianebitencourtdias renaloutcomesinbrazilianpatientswithimmunoglobulinanephropathyandcellularcrescenticlesions
AT luisyu renaloutcomesinbrazilianpatientswithimmunoglobulinanephropathyandcellularcrescenticlesions
AT leonardodeabreutestagrossa renaloutcomesinbrazilianpatientswithimmunoglobulinanephropathyandcellularcrescenticlesions
AT liviabarreiracavalcante renaloutcomesinbrazilianpatientswithimmunoglobulinanephropathyandcellularcrescenticlesions
AT denisemariaavancinicostamalheiros renaloutcomesinbrazilianpatientswithimmunoglobulinanephropathyandcellularcrescenticlesions
AT lecticiabarbosajorge renaloutcomesinbrazilianpatientswithimmunoglobulinanephropathyandcellularcrescenticlesions
AT viktoriaworonik renaloutcomesinbrazilianpatientswithimmunoglobulinanephropathyandcellularcrescenticlesions
_version_ 1724656663510646784